Definium Psychedelics, Visa Reprieve: Readout LOUD — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- The Readout LOUD podcast covered a court decision that gave international researchers a reprieve on foreign visas, though many researchers are still considering leaving the US for opportunities elsewhere.
- STAT reporter Jonathan Wosen and NAFSA executive director Fanta Av joined the episode to discuss what the visa ruling means for the future of American medical research.
- Definium's new psychedelics data was featured on the episode, with discussion of what the findings mean for the broader psychedelics drug field.
- Definium was framed within the emerging psychedelics drug sector, suggesting the company's data carries implications for industry-wide development beyond a single trial readout.
- The episode was hosted by STAT's Elaine Chen, Adam Feuerstein, and Allison DeAngelis, all of whom also co-host the weekly biotech podcast and co-write The Readout newsletter.
Why it matters: A court decision gave international researchers a reprieve on visas, but the source notes many are still considering leaving the US for opportunities elsewhere — potentially affecting staffing pipelines at American medical research institutions if the talent exodus continues.
Ask SkimNews
